ArticleFrontiers in nutrition2026
Screening for medicine and food homologous ingredients targeting ALDH2 to alleviate acute ethanol-induced liver injury.
Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Alcoholic liver disease (ALD) is a major global health burden with limited therapeutic options. Aldehyde dehydrogenase 2 (ALDH2) plays a critical role in alcohol metabolism, and ALDH2 deficiency exacerbates alcohol-induced hepatic injury. Aim: This study aimed to identify and validate natural ALDH2 activators from medicine and food homologous sources for alleviating acute ethanol-induced liver injury. Methods: A literature-based screening revealed 18 candidate compounds. Results: Puerarin, sophoricoside, quercetin, and daidzin were preliminarily identified as mixed-type ALDH2 activators, which increased the acetaldehyde dehydrogenation rate catalyzed by ALDH2. These compounds significantly improved motor coordination, reduced blood ethanol and acetaldehyde levels, attenuated hepatic steatosis, normalized transaminase activities, restored antioxidant capacity, and ameliorated liver histopathological damage in the mouse model. Conclusion: Several natural ALDH2 activators from medicine and food homologous sources with potent hepatoprotective effects were identified, providing the scientific basis for developing healthy foods and dietary supplements to alleviate acute ethanol-induced liver injury.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.